title: The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.
authors.forename: W
authors.initials: W
authors.lastname: Haverkamp
authors.forename: G
authors.initials: G
authors.lastname: Breithardt
authors.forename: A J
authors.initials: AJ
authors.lastname: Camm
authors.forename: M J
authors.initials: MJ
authors.lastname: Janse
authors.forename: M R
authors.initials: MR
authors.lastname: Rosen
authors.forename: C
authors.initials: C
authors.lastname: Antzelevitch
authors.forename: D
authors.initials: D
authors.lastname: Escande
authors.forename: M
authors.initials: M
authors.lastname: Franz
authors.forename: M
authors.initials: M
authors.lastname: Malik
authors.forename: A
authors.initials: A
authors.lastname: Moss
authors.forename: R
authors.initials: R
authors.lastname: Shah
mesh_terms: D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D002309:Cardiology; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004335:Drug and Narcotic Control; D005060:Europe; D006801:Humans; D015221:Potassium Channels / Q000187:drug effects*; D011358:Product Surveillance, Postmarketing; D012106:Research; D012955:Societies, Medical; D016171:Torsades de Pointes / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects
chemical_list: D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D014150:Antipsychotic Agents; D015221:Potassium Channels; D014665:Vasodilator Agents